'Mix and match' COVID-19 study finds Pfizer or Moderna boosters most effective - October 14, 2021

Boeing said it will require nearly 125,000 U.S. employees to receive a COVID-19 vaccination by Dec. 8 under President Joe Biden’s executive order requiring federal employees and contractors to receive the shots. Boeing said its U.S. employees will either need to show proof of vaccination or have an approved medical or religious exemption. Boeing Deals With New Dreamliner Defect Amid Production Problems - The Wall Street Journal Biden employer vaccine mandate could be finalized as early as next week - NBC News Delta Air Lines CEO says 90% of employees are vaccinated against Covid without company mandate - CNBC Stock futures rose Thursday as major banks reported earnings. Bank of America’s third-quarter profit increased 58%, suggesting banks’ lending businesses are improving from a pandemic slump. The second-largest U.S. bank earned $7.69 billion, a $4.88 billion a year increase when compared to a year earlier. Stocks rise as Wall Street wades into bank earnings blizzard - Reuters Economic challenges piling up for the Biden administration - The Washington Post Those who received a Johnson & Johnson coronavirus vaccine are better off getting a booster shot from Pfizer or Moderna, according to preliminary data from a federal clinical trial mixing and matching COVID-19 vaccinations. Although all the vaccine combinations lifted antibody levels, Pfizer's and Moderna’s boosters appeared to have a higher increase in their antibody responses more often than those who received an extra dose of J&J. Johnson & Johnson Covid-19 Booster Shot Bolsters Immune Defense, FDA Staff Say - The Wall Street Journal U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boosters - Reuters What to expect from FDA panel on boosters for Moderna, Johnson & Johnson vaccines - ABC News @Yamiche: A key federal advisory committee is set to begin two days of meetings that are expected to strongly influence decisions on whether at least some recipients of the Moderna and Johnson & Johnson coronavirus vacc